<?xml version="1.0" encoding="UTF-8"?>
<ref id="B12-antibodies-09-00021">
 <label>12.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Shimazaki</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Lepin</surname>
    <given-names>E.J.</given-names>
   </name>
   <name>
    <surname>Wei</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Nagy</surname>
    <given-names>A.K.</given-names>
   </name>
   <name>
    <surname>Coulam</surname>
    <given-names>C.P.</given-names>
   </name>
   <name>
    <surname>Mareninov</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Fu</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Wu</surname>
    <given-names>A.M.</given-names>
   </name>
   <name>
    <surname>Marks</surname>
    <given-names>J.D.</given-names>
   </name>
   <name>
    <surname>Braun</surname>
    <given-names>J.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Diabodies targeting epithelial membrane protein 2 reduce tumorigenicity of human endometrial cancer cell lines</article-title>
  <source>Clin. Cancer Res.</source>
  <year>2008</year>
  <volume>14</volume>
  <fpage>7367</fpage>
  <lpage>7377</lpage>
  <pub-id pub-id-type="doi">10.1158/1078-0432.CCR-08-1016</pub-id>
  <?supplied-pmid 19010852?>
  <pub-id pub-id-type="pmid">19010852</pub-id>
 </element-citation>
</ref>
